Iron Therapy
Iron deficiency (ID) is one of the most common co-morbidities in patients with heart failure (HF). It has its highest prevalence in elderly subjects, women, decompensated subjects, and patients with numerous co-morbidities. ID is associated with worse symptoms, poorer quality of life, reduced exerci...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Barcaray International
2019-01-01
|
| Series: | International Cardiovascular Forum Journal |
| Subjects: | |
| Online Access: | https://icfjournal.org/index.php/icfj/article/view/625/pdf |
| Summary: | Iron deficiency (ID) is one of the most common co-morbidities in patients with heart failure (HF). It has its highest prevalence in elderly subjects, women, decompensated subjects, and patients with numerous co-morbidities. ID is associated with worse symptoms, poorer quality of life, reduced exercise capacity, and a high morbidity and mortality. Both ID and the anaemia it can lead to can be harmful in HF. Repletion of iron stores has been shown to be effective in HF and detection and treatment of ID are now recommended in major HF guidelines. This paper summarises iron therapy for ID in HF patients. |
|---|---|
| ISSN: | 2410-2636 2409-3424 |